- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Nuuvera announced it closed the transaction to acquire FL-Group, Genoa-based company.
Nuuvera (TSXV:NUU) announced it closed the transaction to acquire FL-Group, Genoa-based company.
As quoted in the press release:
The acquisition, originally announced on January 18, 2018, makes Nuuvera the first Canadian cannabis company to hold a license to serve the Italian market.
This strategic international acquisition follows the recent decision by the Italian National Health System to reimburse medical cannabis prescription costs, and reinforces Nuuvera as one of the foremost global cannabis companies, with a footprint in Germany, Italy, Spain, Israel, and Malta.
Lorne Abony, CEO of Nuuvera, said that Nuuvera is thrilled to finalize the agreement with FL-Group, and to be the first international cannabis company to be licensed to serve Italian customers.
Source: www.newswire.ca
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.Â